News
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
2d
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
Researchers use targeted lipid nanoparticles loaded with mRNA to reprogram T cells to fight autoimmune diseases ...
A nanoneedle patch painlessly extracts molecular data, offering a safer, repeatable alternative to traditional biopsies for ...
Many people can have polyps and, like Andy, have no symptoms. A polyp can take as many as 10 to 15 years to develop into ...
The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...
9d
Pharmaceutical Technology on MSNGilead eyes Kymera’s ‘adhesive’ cancer drug in $750m dealKymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.
Scientists discover how cells absorb queuosine, a vital nutrient affecting memory, learning, and cancer resistance.
8d
News-Medical.Net on MSNStudy finds overlap between chemotherapy side effects and brain agingWhile chemotherapy can be lifesaving, it also damages DNA and leads to cognitive issues known as "chemo brain." These effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results